Dai Takeuchi

639 total citations · 1 hit paper
23 papers, 432 citations indexed

About

Dai Takeuchi is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Dai Takeuchi has authored 23 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Dai Takeuchi's work include HER2/EGFR in Cancer Research (5 papers), Parathyroid Disorders and Treatments (3 papers) and Thyroid and Parathyroid Surgery (3 papers). Dai Takeuchi is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Parathyroid Disorders and Treatments (3 papers) and Thyroid and Parathyroid Surgery (3 papers). Dai Takeuchi collaborates with scholars based in Japan and United States. Dai Takeuchi's co-authors include Hisakazu Shindo, Kiyomi Y. Hames, Yusaku Yoshida, Iwao Sugitani, Hirotaka Nakayama, Toshiharu Kanai, Chie Masaki, Isao Tabei, Mitsuyoshi Hirokawa and Akira Miyauchi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Journal of Virology.

In The Last Decade

Dai Takeuchi

21 papers receiving 429 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma

2020 248 citations Iwao Sugitani, Yasuhiro Ito et al. Thyroid profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dai Takeuchi Japan	9	277	224	81	65	57	23	432
Zbigniew Wygoda Poland	11	344 1.2×	183 0.8×	111 1.4×	60 0.9×	89 1.6×	29	512
Luciana Puleo Italy	8	374 1.4×	115 0.5×	104 1.3×	113 1.7×	46 0.8×	11	480
Celso U. M. Friguglietti Brazil	14	452 1.6×	271 1.2×	179 2.2×	69 1.1×	35 0.6×	19	642
Augusto Taccaliti Italy	14	254 0.9×	151 0.7×	99 1.2×	87 1.3×	21 0.4×	29	422
Beata Jurecka‐Lubieniecka Poland	13	254 0.9×	80 0.4×	85 1.0×	59 0.9×	28 0.5×	31	465
Vlasta Sýkorová Czechia	12	386 1.4×	129 0.6×	109 1.3×	143 2.2×	30 0.5×	18	501
Claire Coire Canada	13	216 0.8×	140 0.6×	58 0.7×	72 1.1×	8 0.1×	18	415
Hanh Thi Tuyet Ngo Vietnam	9	194 0.7×	80 0.4×	64 0.8×	52 0.8×	44 0.8×	14	338
C Zampatti Italy	10	172 0.6×	186 0.8×	54 0.7×	143 2.2×	18 0.3×	22	456
L Colombo Italy	9	561 2.0×	347 1.5×	43 0.5×	86 1.3×	39 0.7×	17	663

Countries citing papers authored by Dai Takeuchi

Since Specialization

Citations

This map shows the geographic impact of Dai Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dai Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dai Takeuchi more than expected).

Fields of papers citing papers by Dai Takeuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dai Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dai Takeuchi. The network helps show where Dai Takeuchi may publish in the future.

Co-authorship network of co-authors of Dai Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Dai Takeuchi. A scholar is included among the top collaborators of Dai Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dai Takeuchi. Dai Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takeuchi, Dai, et al.. (2024). FeLIX is a restriction factor for mammalian retrovirus infection. Journal of Virology. 98(4). e0177123–e0177123. 1 indexed citations

Shibata, Masahiro, et al.. (2023). A Case of Male Breast Cancer Occuring Away from the Nipple. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 84(4). 528–531.

Kikumori, Toyone, Masahiro Shibata, & Dai Takeuchi. (2021). Development of a Rapid Intraoperative Point‐of‐Care Method Using Tissue Suspension to Differentiate Parathyroid Tissue: A Possible Substitute for Frozen Sections. World Journal of Surgery. 45(7). 2142–2145.

Shibata, Masahiro, Takahiro Ichikawa, Dai Shimizu, et al.. (2021). Identifying the tumor-progressive gene expression profile in high-risk papillary thyroid cancer. Surgery Today. 51(10). 1703–1712. 8 indexed citations

Ichikawa, Takahiro, Masahiro Shibata, Mitsuro Kanda, et al.. (2021). Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer. Current Oncology. 28(5). 4080–4092. 4 indexed citations

Miyajima, Noriyuki, Ibrahim Ragab Eissa, Yoshinori Naoe, et al.. (2021). S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model.. PubMed. 83(4). 683–696. 2 indexed citations

Sugitani, Iwao, Yasuhiro Ito, Dai Takeuchi, et al.. (2020). Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma. Thyroid. 31(2). 183–192. 248 indexed citations breakdown →

Shibata, Masahiro, et al.. (2020). Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study.. PubMed. 82(3). 457–467. 5 indexed citations

Shibata, Masahiro, et al.. (2020). Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases. Breast Cancer. 27(6). 1065–1071. 6 indexed citations

10.

Shibata, Masahiro, Takahiro Ichikawa, Noriyuki Miyajima, et al.. (2020). MZB1 expression indicates poor prognosis in estrogen receptor‑positive breast cancer. Oncology Letters. 20(5). 1–1. 21 indexed citations

11.

Kikumori, Toyone, et al.. (2020). Measurement of the AST to LD Ratio in Parathyroid Tissue Suspension Can Precisely Differentiate a Hyperfunctioning Parathyroid. The Journal of Clinical Endocrinology & Metabolism. 105(8). e2764–e2769. 2 indexed citations

12.

Kikumori, Toyone, et al.. (2019). Robust, quick, and convenient intraoperative method to differentiate parathyroid tissue. Surgery. 167(2). 385–389. 6 indexed citations

13.

Nakanishi, Kenichi, Toyone Kikumori, Noriyuki Miyajima, et al.. (2018). Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma. Clinical Nuclear Medicine. 43(7). 482–485. 17 indexed citations

14.

Shibata, Masahiro, Mitsuro Kanda, Dai Shimizu, et al.. (2018). RASEF expression correlates with hormone receptor status in breast cancer. Oncology Letters. 16(6). 7223–7230. 4 indexed citations

15.

Shibata, Masahiro, Noriyuki Miyajima, Yayoi Adachi, et al.. (2017). Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report. SHILAP Revista de lepidopterología. 3(1). 131–131. 9 indexed citations

16.

Shibata, Masahiro, Mitsuro Kanda, Haruyoshi Tanaka, et al.. (2017). Overexpression of Derlin 3 is associated with malignant phenotype of breast cancer cells. Oncology Reports. 38(3). 1760–1766. 23 indexed citations

17.

Morita, Sachi, Toyone Kikumori, Nobuyuki Tsunoda, et al.. (2017). Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan. International Journal of Clinical Oncology. 23(1). 195–200. 6 indexed citations

18.

Shibata, Masahiro, Mitsuro Kanda, Dai Shimizu, et al.. (2017). Expression of regulatory factor X1 can predict the prognosis of breast cancer. Oncology Letters. 13(6). 4334–4340. 6 indexed citations

19.

Araki, Jun, Hiromi Sakai, Dai Takeuchi, et al.. (2015). Normothermic Preservation of the Rat Hind Limb With Artificial Oxygen-carrying Hemoglobin Vesicles. Transplantation. 99(4). 687–692. 27 indexed citations

20.

Adachi, Yayoi, Toyone Kikumori, Noriyuki Miyajima, et al.. (2015). Postoperative elevation of CA15-3 due to pernicious anemia in a patient without evidence of breast cancer recurrence. Surgical Case Reports. 1(1). 126–126. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact